Mark Schoenberg

13.1k total citations · 1 hit paper
218 papers, 9.1k citations indexed

About

Mark Schoenberg is a scholar working on Surgery, Urology and Molecular Biology. According to data from OpenAlex, Mark Schoenberg has authored 218 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Surgery, 58 papers in Urology and 32 papers in Molecular Biology. Recurrent topics in Mark Schoenberg's work include Bladder and Urothelial Cancer Treatments (173 papers), Urinary and Genital Oncology Studies (120 papers) and Urological Disorders and Treatments (51 papers). Mark Schoenberg is often cited by papers focused on Bladder and Urothelial Cancer Treatments (173 papers), Urinary and Genital Oncology Studies (120 papers) and Urological Disorders and Treatments (51 papers). Mark Schoenberg collaborates with scholars based in United States, Canada and Germany. Mark Schoenberg's co-authors include David Sidransky, Seth P. Lerner, Shahrokh F. Shariat, Arthur I. Sagalowsky, Pierre I. Karakiewicz, Yair Lotan, Patrick J. Bastian, Ganesh S. Palapattu, Craig Rogers and Amnon Vazina and has published in prestigious journals such as Science, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Mark Schoenberg

212 papers receiving 8.9k citations

Hit Papers

Outcomes of Radical Cystectomy for Transitional Cell Carc... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Schoenberg United States 53 6.6k 2.4k 2.2k 1.9k 1.6k 218 9.1k
Patrick J. Bastian Germany 58 4.7k 0.7× 2.3k 0.9× 2.8k 1.3× 1.4k 0.7× 4.6k 2.8× 188 10.4k
John P. Stein United States 55 9.6k 1.5× 4.5k 1.9× 1.9k 0.9× 2.2k 1.1× 2.2k 1.4× 182 11.8k
Pramod C. Sogani United States 49 6.2k 0.9× 1.3k 0.5× 1.3k 0.6× 1.4k 0.7× 2.3k 1.4× 114 7.9k
Fredrik Liedberg Sweden 35 4.6k 0.7× 945 0.4× 1.7k 0.8× 1.2k 0.6× 1.5k 0.9× 175 5.8k
Louis Lacombe Canada 39 2.7k 0.4× 703 0.3× 1.6k 0.7× 3.4k 1.8× 3.0k 1.8× 179 7.2k
Robert Dreicer United States 48 3.8k 0.6× 671 0.3× 2.3k 1.1× 3.3k 1.7× 2.9k 1.8× 179 8.3k
Andrea Haitel Austria 42 1.7k 0.3× 618 0.3× 2.0k 0.9× 1.1k 0.6× 2.3k 1.4× 153 5.3k
Charles C. Guo United States 38 3.0k 0.5× 628 0.3× 1.6k 0.7× 986 0.5× 2.0k 1.2× 136 5.4k
Lance C. Pagliaro United States 41 2.1k 0.3× 452 0.2× 1.6k 0.7× 2.1k 1.1× 2.4k 1.4× 199 5.9k
V. O. Speights United States 27 2.3k 0.4× 854 0.4× 736 0.3× 851 0.5× 1.5k 0.9× 59 4.4k

Countries citing papers authored by Mark Schoenberg

Since Specialization
Citations

This map shows the geographic impact of Mark Schoenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schoenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schoenberg more than expected).

Fields of papers citing papers by Mark Schoenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schoenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schoenberg. The network helps show where Mark Schoenberg may publish in the future.

Co-authorship network of co-authors of Mark Schoenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Schoenberg. A scholar is included among the top collaborators of Mark Schoenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Schoenberg. Mark Schoenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, David, et al.. (2025). HOME INSTILLATION OF UGN-102 FOR PRIMARY CHEMOABLATION OF RECURRENT LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER: A SINGLE-ARM, OPEN-LABEL, PHASE 3B TRIAL. Urologic Oncology Seminars and Original Investigations. 43(3). 50–50. 1 indexed citations
2.
Prasad, Sandip M., William C. Huang, Neal D. Shore, et al.. (2024). PD30-09 RESPONSE TO PRIMARY CHEMOABLATION WITH UGN-102 IN PATIENTS WITH NEW OR RECURRENT LG IR NMIBC: POST-HOC ANALYSIS OF THE ATLAS TRIAL. The Journal of Urology. 211(5S). 1 indexed citations
3.
Semerjian, Alice, Max Kates, Michael A. Gorin, et al.. (2017). Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era. Urology. 111. 86–91. 46 indexed citations
4.
Schoenberg, Mark, et al.. (2016). The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2(3). 285–292. 40 indexed citations
5.
Chalfin, Heather J., Jen-Jane Liu, Nilay Gandhi, et al.. (2016). Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy. Annals of Surgical Oncology. 23(8). 2715–2722. 28 indexed citations
6.
Kaye, Deborah R., Joseph K. Canner, Max Kates, Mark Schoenberg, & Trinity J. Bivalacqua. (2016). Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference. Bladder Cancer. 2(2). 225–234. 20 indexed citations
7.
Reis, Leonardo Oliveira, Diana Taheri, Alcides Chaux, et al.. (2015). Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Human Pathology. 47(1). 20–25. 44 indexed citations
8.
9.
Kinde, Isaac, Enrico Munari, Sheila F. Faraj, et al.. (2013). TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine. Cancer Research. 73(24). 7162–7167. 200 indexed citations
10.
Kates, Max, Michael A. Gorin, Christopher M. Deibert, et al.. (2013). In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States. Urologic Oncology Seminars and Original Investigations. 32(1). 53.e9–53.e14. 13 indexed citations
11.
Guzzo, Thomas J., Ahmed Magheli, Trinity J. Bivalacqua, et al.. (2009). Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer. Urology. 74(6). 1276–1280. 30 indexed citations
12.
Schoenberg, Mark, et al.. (2008). MP-2.24: Bladder Cancer Incidence and Mortality Among Workers Exposed to Benzidine and 3,3-Dichlorobenzidine. Urology. 72(5). S74–S75. 1 indexed citations
13.
Semins, Michelle J. & Mark Schoenberg. (2007). A case of florid cystitis glandularis. Nature Clinical Practice Urology. 4(6). 341–345. 25 indexed citations
14.
Nielsen, Matthew E., Patrick J. Bastian, Ganesh S. Palapattu, et al.. (2007). Recurrence-Free Survival After Radical Cystectomy of Patients Downstaged by Transurethral Resection. Urology. 70(6). 1091–1095. 11 indexed citations
15.
Nielsen, Matthew E., Edward M. Schaeffer, Robert W. Veltri, Mark Schoenberg, & Robert H. Getzenberg. (2006). Urinary markers in the detection of bladder cancer: what's new?. Current Opinion in Urology. 16(5). 350–355. 20 indexed citations
16.
Nielsen, Matthew E., Mark L. Gonzalgo, Mark Schoenberg, & Robert H. Getzenberg. (2006). Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer. World Journal of Urology. 24(5). 499–508. 14 indexed citations
17.
Parsons, J. Kellogg, et al.. (2003). Rectus abdominis vaginoplasty after anterior exenteration for urologic malignancy. Urology. 61(6). 1249–1252. 8 indexed citations
18.
Halachmi, Sarel, Angelo M. De Marzo, Nan‐Haw Chow, et al.. (2000). Genetic Alterations in Urinary Bladder Carcinosarcoma: Evidence of a Common Clonal Origin. European Urology. 37(3). 350–357. 51 indexed citations
19.
Steiner, Gabriel, Mark Schoenberg, Jürgen F. Linn, Li Mao, & David Sidransky. (1997). Detection of bladder cancer recurrence by microsatellite analysis of urine. Nature Medicine. 3(6). 621–624. 224 indexed citations
20.
Schoenberg, Mark, et al.. (1984). Induction of Proteins in Human Lymphoblastoid Cells by Recombinant Alpha Interferon. Journal of Interferon Research. 4(1). 67–79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026